Top compounds associated with response to RABL6


Feature Type Standardized
Nominal ANOVA
mRNA Mdivi-1 CTRPv2 pan-cancer AAC -0.026 0.5
mRNA SB-431542 CTRPv2 pan-cancer AAC 0.027 0.5
mRNA Nilotinib CTRPv2 pan-cancer AAC 0.026 0.5
mRNA isoevodiamine CTRPv2 pan-cancer AAC 0.023 0.5
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.024 0.5
mRNA Erlotinib gCSI pan-cancer AAC -0.041 0.5
mRNA BRD-K27224038 CTRPv2 pan-cancer AAC -0.052 0.5
mRNA DMOG GDSC1000 pan-cancer AAC -0.023 0.5
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.024 0.5
mRNA ML258 CTRPv2 pan-cancer AAC -0.026 0.5
Download CSV